Real-World Effectiveness of a Triple Combination BDP/FF/GB in a Single Pressurised Metered Dose Inhaler in COPD Patients (TRIPHY)

Active, not recruitingOBSERVATIONAL
Enrollment

359

Participants

Timeline

Start Date

July 2, 2024

Primary Completion Date

October 15, 2025

Study Completion Date

October 15, 2025

Conditions
Chronic Obstructive Pulmonary Disease
Trial Locations (18)

102300

Site 156110 Beijing Jingmei Group Genetal Hospital, Beijing

210008

Site 156125 - Nanjing Drum Tower Hospital, Nanjing

250021

Site 156109 - Shandong Provincial Hospital, Jinan

312000

Site 156103 - Shaoxing People's Hospital, Shaoxing

313000

Site 156106 - Huzhou Central Hospital, Huzhou

315010

Site 156112 - The First Affiliated Hospital of Ningbo University, Ningbo

317599

Site 156123 - Wenling People's Hospital, Wenling

318000

Site 156105 - Taizhou Central Hospital, Taizhou

321083

Site 156115 - Jinhua Central Hospital, Jinhua

323088

Site 156124 - Lishui People's Hospital, Lishui

450003

Site 156108 - Henan Provincial People's Hospital, Zhengzhou

Site 156102 - Mianyang Central Hospital, Mianyang

510120

Site 156101 - The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

510260

Site 156113 - The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

524003

Site 156114 - The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang

618000

Site 156122 - Deyang People's Hospital, Deyang

710004

Site 156117 - The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an

830054

Site 156121 - The First Affiliated Hospital of Xinjiang Medical University, Ürümqi

All Listed Sponsors
lead

Chiesi Farmaceutici S.p.A.

INDUSTRY

NCT06480890 - Real-World Effectiveness of a Triple Combination BDP/FF/GB in a Single Pressurised Metered Dose Inhaler in COPD Patients (TRIPHY) | Biotech Hunter | Biotech Hunter